600600:SSETsingtao Brewery Co., Ltd. Class A Analysis
Data as of 2026-03-15 - not real-time
CN¥63.42
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Tsingtao Brewery is trading at CNY 63.42, just below the 20‑day resistance of CNY 63.89 and above the 20‑day support of CNY 61.01. The 20‑day and 50‑day SMAs (CNY 62.34 and CNY 62.08) sit beneath the current price, indicating a modest upward bias. Momentum indicators are mixed: RSI 59 suggests the stock is not yet overbought, while the MACD histogram is positive (0.16) and the MACD signal is bullish. Volume is increasing, supporting the recent price gain. However, the DCF‑derived fair value of CNY 43.87 is far below the market price, flagging a substantial overvaluation. The dividend yield of 3.47 % and a payout ratio of 65 % provide attractive income, but the price premium limits upside.
Fundamentals show stable profitability with a gross margin of 41.7 % and operating margin of 22 %, while revenue is essentially flat year‑over‑year. Strong cash generation (CNY 4.74 bn operating cash flow) and a modest debt‑to‑equity of 0.36 give the balance sheet ample headroom. The company's beta is near zero, indicating low market sensitivity, and the 30‑day volatility of 26.8 % is moderate for a consumer‑defensive stock. Sector risk is low, but regulatory risk around alcohol sales is medium, and geographic exposure is concentrated in China (medium risk). Liquidity is solid, with daily volumes above the 10‑day average and a market cap of CNY 86.5 bn. Given the overvaluation but strong dividend and defensive profile, a neutral stance is warranted in the short term, with a tilt toward buying on any pull‑back for long‑term value investors.
Fundamentals show stable profitability with a gross margin of 41.7 % and operating margin of 22 %, while revenue is essentially flat year‑over‑year. Strong cash generation (CNY 4.74 bn operating cash flow) and a modest debt‑to‑equity of 0.36 give the balance sheet ample headroom. The company's beta is near zero, indicating low market sensitivity, and the 30‑day volatility of 26.8 % is moderate for a consumer‑defensive stock. Sector risk is low, but regulatory risk around alcohol sales is medium, and geographic exposure is concentrated in China (medium risk). Liquidity is solid, with daily volumes above the 10‑day average and a market cap of CNY 86.5 bn. Given the overvaluation but strong dividend and defensive profile, a neutral stance is warranted in the short term, with a tilt toward buying on any pull‑back for long‑term value investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with limited upside
- Significant overvaluation versus DCF fair value
- Attractive dividend yield supporting income focus
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash flow and low debt
- Defensive consumer sector providing stability
- Dividend sustainability despite premium valuation
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta and defensive positioning
- Robust balance sheet with high free cash flow
- Potential price correction aligning market price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth-0.20%
Profit Margin14.22%
P/E Ratio18.7
ROE15.15%
ROA6.20%
Debt/Equity0.36
P/B Ratio2.8
Op. Cash FlowCN¥4.7B
Free Cash FlowCN¥2.9B
Technical Analysis
TrendNeutral
RSI59.2
SupportCN¥61.01
ResistanceCN¥63.89
MA 20CN¥62.34
MA 50CN¥62.08
MA 200CN¥66.42
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥43.87
GradeOvervalued
TypeValue
Dividend Yield3.47%
Risk Assessment
Beta-0.02
Volatility26.79%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.